Baselga, J., Zamagni, C., Gómez, P., Bermejo, B., Nagai, S., Melichar, B., . . . Schwartzberg, L. (2017). RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer.
Chicago Style (17th ed.) CitationBaselga, J., et al. RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer. 2017.
MLA (9th ed.) CitationBaselga, J., et al. RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer. 2017.
Warning: These citations may not always be 100% accurate.